NCT05660239

Brief Summary

The goal of this community based observation study is to co-create solutions that empower people to make informed decisions about epilepsy, reduce stigma, and promote community health among the adolescent population living with epilepsy in Uganda. The main objectives of the study are to: Goal 1: Co-create a unique patient-community engagement program (CEP) to reduce stigma on epilepsy among adolescents and their caregivers in Uganda based on understanding of the illness. Goal 2: Evaluate the impact of this CEP to reduce stigma on epilepsy among adolescents and their caregivers in Uganda, based on understanding of the illness. Study participants together with the relevant community stakeholders will co-design feasible communication and activity-based change projects that are based on both cultural and scientific norms, to reduce epilepsy stigma in the community Researchers will then compare the Quality of Life, Attitudes and Beliefs about Living with Epilepsy scores (as a surrogate of stigmatizing beliefs and practices among community members) and the Kilifi Stigma Scale scores in two parishes (urban and rural) to see if there is improvement in these assessments scores following the implementation of the community change projects.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
3mo left

Started Mar 2024

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Mar 2024Sep 2026

First Submitted

Initial submission to the registry

December 7, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 21, 2022

Completed
1.2 years until next milestone

Study Start

First participant enrolled

March 1, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Expected
Last Updated

September 5, 2023

Status Verified

August 1, 2023

Enrollment Period

2 years

First QC Date

December 7, 2022

Last Update Submit

August 30, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • Attitudes and Beliefs about Living with Epilepsy (ABLE) scores among the community stigma reduction implementation team.

    Change in knowledge, attitude and beliefs regarding epilepsy among the community stigma reduction implementation team. Attitudes and Beliefs about Living with Epilepsy (ABLE) scale, are scored on a five-point Likert scale (1=no stigma, 5=high stigma)

    two years

  • Attitudes and Beliefs about Living with Epilepsy (ABLE) scores among the non-community stigma reduction implementation team.

    Change in knowledge, attitude and beliefs regarding epilepsy among the non-community stigma reduction implementation team. Attitudes and Beliefs about Living with Epilepsy (ABLE) scale, are scored on a five-point Likert scale (1=no stigma, 5=high stigma).

    two years

  • Kilifi Stigma Scale scores among adolescents with epilepsy

    Change in perceived stigma for the adolescents living with epilepsy. Kilifi Stigma scale has a three-point Likert scoring, (0 = not at all, 1 = sometimes, 2 = always). A total score is calculated by addition of all item scores. The higher the score, the greater the sense of perceived stigma.

    two years

  • Quality of Life for Epilepsy in Adolescents scores

    Change in the quality of life for the adolescents living with epilepsy. Quality of Life(QoL) for Epilepsy in Adolescents scores are on a 5-point Likert scale with: 1 = poor; and 5 = excellent. Ratings are linearly transformed, providing total scores from 0 (low QoL) to 100 (high QoL).

    two years

Secondary Outcomes (2)

  • Beck Youth Inventory for depression (BDI-Youth) scores among adolescents with epilepsy

    two years

  • Columbia Suicide Severity Rating Scale (C-SSRS) scores for the adolescents living with epilepsy.

    two years

Study Arms (2)

Wakiso district-Urban Parish

OTHER

Study participants together with the relevant community stakeholders will co-design feasible communication and activity-based change projects that are based on both cultural and scientific norms, to reduce epilepsy stigma in the community. Researchers will then compare the Quality of Life, Attitudes and Beliefs about Living with Epilepsy scores and the Kilifi Stigma Scale scores following the implementation of the community change projects in an urban parish to see if there is improvement in these assessments scores.

Other: Community Intervention

Wakiso district-Rural Parish

OTHER

Study participants together with the relevant community stakeholders will co-design feasible communication and activity-based change projects that are based on both cultural and scientific norms, to reduce epilepsy stigma in the community. Researchers will then compare the Quality of Life, Attitudes and Beliefs about Living with Epilepsy scores and the Kilifi Stigma Scale scores following the implementation of the community change projects in a rural parish to see if there is improvement in these assessments scores.

Other: Community Intervention

Interventions

To evaluate the impact of a community intervention in reducing epilepsy stigma in adolescents.

Wakiso district-Rural ParishWakiso district-Urban Parish

Eligibility Criteria

Age10 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Adolescent with epilepsy residing in Wakiso district
  • Between the ages 10-18 years
  • A resident of Wakiso district, Uganda for the previous six months
  • Confirmed diagnosis for epilepsy as per the International League Against Epilepsy definition
  • Provide written assent to participation in the study
  • With a caregiver willing to provide written informed consent as well as detailed history regarding them.
  • Willing to participate in all the required program activities with his/her caregiver

You may not qualify if:

  • Adolescent with epilepsy residing in Wakiso district who
  • Does not have the time or interest to participate in the community engagement program
  • Has had exposure to a similar previous community engagement program
  • Is unable to fully understand what is required of him/her in the study and engage consistently throughout the whole community engagement program

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Epilepsy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Study participants and researchers both know which community change intervention they are receiving or implementing respectively.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Study participants together with the relevant community stakeholders will co-design feasible communication and activity-based change projects that are based on both cultural and scientific norms, to reduce epilepsy stigma in the community Researchers will then compare the Quality of Life, Attitudes and Beliefs about Living with Epilepsy scores and the Kilifi Stigma Scale scores, pre and post the implementation of the community change projects in two parishes (urban and rural) to see if there is improvement in these assessments scores.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 7, 2022

First Posted

December 21, 2022

Study Start

March 1, 2024

Primary Completion

March 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

September 5, 2023

Record last verified: 2023-08